Dr. Jonathan Brody is the Vice Chair of Research for the Dept. of Surgery and is the Associate Director of Translational Research of the Brenden-Colson Pancreatic Center for Patient Care. He was a member and co-leader of the GI Cancer Program at the Sidney Kimmel Cancer Center (Thomas Jefferson University 2006-2020). Dr. Brody received his Ph.D. from The Johns Hopkins University School of Medicine, and his thesis specialized in studying the molecular aspects of cancer and cancer genetics. He patented, with Dr. Scott Kern, novel buffers for DNA identification (DNA electrophoresis buffer), that have changed the format of this molecular biology technique used to detect DNA. He was elected Chair of the Cancer Research Program (PRCRP), Department of Defense council and serves on many international study sections, including currently being the Chair of the Tumor Biology and Genomics study section for the American Cancer Society and a permanent member of the Cancer Prevention Study Section NCI study section panel. He has published over 135 peer review publications in many top tier scientific and cancer journals. Additionally, he was an American Cancer Society Research Scholar, is NIH (NCI, R01) funded, and won the American Association of Cancer Research, Pancreatic Cancer Career Development Award in 2010.
James Carroll, B.S.
Roberto DiNiro, Ph.D.
Dr. DiNiro trained as a molecular biologist and earned his PhD in his home country of Italy. He has since worked in the biotechnology and immunology fields in Oslo, Norway, and in the United States at Yale University. Roberto joins the Brody group as lab manager, with the goal of providing logistic support to all the activities in the lab. Outside of science, Roberto loves everything outdoors.
Jen is a PhD candidate in PBMS from Vermont who studied Biochemistry at St. Lawrence University in Upstate New York before working as a research technician at the University of Pennsylvania in Philadelphia. She is now studying the role of PDAC-derived extracellular vesicles in the tumor microenvironment. Specifically, the role of HuR in the production and stromal response to PDAC-derived extracellular vesicles. In addition to her research, she embraces her roots in Vermont by cooking with maple syrup, hiking and skiing.
Grace is a 5th year PhD candidate. Grace joined the lab in 2018 at Jefferson University in Philadelphia. Since then, she has transferred to OHSU to continue her graduate studies in the Brody lab. Her thesis work revolves around investigating the role of HuR in pancreatic ductal adenocarcinoma metastasis. Additionally, she works closely with the company Code Bio in developing a targeted nanocarrier to silence HuR for treatment of pancreatic cancer. Outside her studies, Grace enjoys hiking, playing tennis, and pulling pranks on her lab mates